In this video interview, Kimberly Tableman, founder & CEO, ESPERO, talks protocol submission formats and how data interoperability can support artificial intelligence.
In the pivotal trial, patients treated with Omvoh experienced significant improvements in clinical remission and endoscopic response at one year. The FDA has approved Eli Lilly’s Omvoh ...
An updated long-term analysis of the Phase III KATHERINE trial confirms that adjuvant treatment with Kadcyla (trastuzumab emtansine) significantly improves overall survival and long-term invasive ...
In 2025, sponsors will prioritize contract research organizations (CROs) offering complete and continuous data transparency ...
In this video interview, Kimberly Tableman, founder & CEO, ESPERO, discusses historical challenges with long protocol ...
Pilot trial shows that a user-friendly electronic patient-reported outcome (ePRO) monitoring system significantly improves ...
Suvoda and Greenphire have announced an agreement to merge. The merger will unite both clinical technology vendors to offer an end-to-end platform for clinical trials. Under the terms of the agreement ...
Recent research from the Tufts CSDD gauged progress in the context of the “Chief Diversity Officer” role at top pharmaceutical companies. Depending on who you ask, opinions on the state of diversity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback